5-HT3 receptor inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 5-HT3 receptor inhibitor, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery [NA]